SCHEMBL3701950

SCHEMBL3701950

CCOC(=O)CN(CCc1ccc([N+](=O)[O-])cc1)C(=O)CC1C(=O)N(C(Cl)Cc2ccc(Cl)cc2)CC(=O)N1CCCN1CCOCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 4/20 0.36
KCNH2 Q12809 1/20 0.36
APAF1 O14727 3/20 0.33
CASP3 P42574 3/20 0.33
CASP9 P55211 3/20 0.33
CYCS P99999 3/20 0.33
RXFP1 Q9HBX9 1/20 0.32
ALDH1A1 P00352 5/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 3/20 0.32
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPC1 O15118 2/20 0.32
USP2 O75604 1/20 0.32
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TP53 P04637 1/20 0.31
MDM2 Q00987 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3705051 0.94 APAF1 (0.36) APAF1CASP3CASP9CYCSALDH1A1
SCHEMBL3697424 0.92 APAF1 (0.34) APAF1CASP3CASP9CYCSALDH1A1
SCHEMBL9101546 0.91 C5AR1 (0.39) APAF1CASP3CASP9CYCSALDH1A1
SCHEMBL3696385 0.90 PTGS2 (0.37) KCNH2APAF1CASP3CASP9CYCS
SCHEMBL3702398 0.89 APAF1 (0.35) KCNJ1KCNH2APAF1CASP3CASP9
SCHEMBL3700914 0.88 TSHR (0.41) APAF1CASP3CASP9CYCSALDH1A1
SCHEMBL3705169 0.86 ALDH1A1 (0.36) APAF1CASP3CASP9CYCSALDH1A1
SCHEMBL3708097 0.85 TSHR (0.34) ALDH1A1KDM4EUSP2TSHRNPSR1
SCHEMBL3710700 0.85 MDM2 (0.38) ALDH1A1KDM4ESMN1; SMN2USP2TSHR
SCHEMBL3701947 0.84 APAF1 (0.49) KCNJ1KCNH2APAF1CASP3CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9040701-B2 Apaf-1 inhibitor compounds LABORATORIOS SALVAT, S.A. (ES) 2015-05-26 US disclosed
US-20120122868-A1 APAF-1 INHIBITOR COMPOUNDS LABORATORIOS SALVAT, S.A. (ES) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122868-A1 APAF-1 INHIBITOR COMPOUNDS APAF1, API5, AIFM1 KCNJ1 3481/4885KCNH2 3647/4885APAF1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.